MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

Biomedicines, Free Full-Text

SBP-0636457, a SMAC Mimetic, is an IAP Antagonist

Ganitumab (AMG 479) is an IGF1R mAb for Cancer Research

SP-146 is a Selective and non-ATP-Competitive Aurora B Inhibitor

SC99 is an Orally Active and Selective STAT3 Inhibitor

A combination of novel NSC small molecule inhibitor along with

A novel small molecule STAT3 inhibitor SLSI-1216 suppresses

CYD-2-11 is a Selective Bax Agonist for Breast and Lung Cancer Research

RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone

RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone

MSAB is a Selective Inhibitor of Wnt/β-Catenin Signaling

MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer